Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach
ConclusionOur results suggest that the current cost-effectiveness threshold used in China is too high; continuing to use it risks decisions that reduce overall population health.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: China Health | Disability | Health Management | International Medicine & Public Health | Legislation | Study | WHO